Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Odonate Therapeutics, LLC (ODT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10yOdonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer.

Sector: Healthcare
Industry: Pharmaceuticals

CEO: Kevin C. Tang
http://www.odonate.com
Price: $21.01 Metrics
OS: 26.9 M
Market cap: $565 M
Net cash: $177 M $6.60 per share
EV: $388 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues27.92.60.0
            Revenue growth964.1%  
Cost of goods sold32.73.10.2
Gross profit-4.8-0.5-0.2
            Gross margin-17.4%-17.7% 
Selling, general and administrative  0.0
General and administrative4.80.50.0
EBIT-37.6-3.5-0.2
            EBIT margin-134.7%-135.3% 
Pre-tax income-32.7-3.10.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-32.7-3.10.0
            Net margin-117.4%-117.7% 
 
Diluted EPS($2.31)($0.54) 
Shares outstanding (diluted)14.25.8 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy